In millions, except per share items | Sep-30-22 | Jun-30-22 | Mar-31-22 | Sep-30-21 |
| 10-Q | 10-Q | 10-Q | 10-Q |
Cash flows from operating activities: | | | | |
Net income (loss) | -0.8 | 1.6 | 7.2 | -0.1 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | | | | |
Interest earned on marketable securities held in Trust Account | | | | |
Warrant issuance costs | | | | |
Unrealized gain on change in fair value of warrants | | | | |
Gain on expiration of overallotment option | | | | |
Changes in operating assets and liabilities: | | | | |
Prepaid expenses | 0.1 | 0.1 | -0.6 | |
Accounts payable and accrued expenses | 0.0 | 0.1 | 0.0 | 0.1 |
Net cash used in operating activities | -0.1 | -0.2 | -0.8 | |
|
Cash flows from investing Activities: | | | | |
Principal deposited in Trust Account | | | -132.6 | |
Net cash used in investing activities | | | -132.6 | |
|
Cash flows from financing Activities: | | | | |
Proceeds from initial public offering, net of underwriters' discount | | | 127.4 | |
Proceeds from private placement | | | 7.9 | |
Payment of Sponsor promissory note | | | -0.1 | |
Payment of deferred offering costs | | | -0.3 | |
Net cash provided by financing activities | | | 134.9 | |
Net change in cash | -0.1 | -0.2 | 1.4 | |
|
Supplemental disclosure of cash flow information: | | | | |
Deferred offering costs included in accounts payable and accrued offering costs and expenses | | 0.0 | | 0.2 |
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | | | | 0.0 |
Remeasurement of Class A ordinary shares to redemption amount | | 15.4 | | |
Deferred underwriting commissions payable charged to additional paid in capital | | | 4.6 | |
Deferred offering costs charged to additional paid in capital | | | 0.5 | |
Forfeiture of 487,500 founder shares on expiration of overallotment option | | | 0.0 | |
Initial fair value of warrant liability | | | 10.9 | |
Deferred offering costs charged to accumulated deficit | | | 0.1 | |